MoonLake Immunotherapeutics is a clinical-stage biotechnology company focused on generating novel therapies for inflammatory diseases, particularly in the areas of dermatology and rheumatology.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!